Natus welcomes Optima Medical to the Natus family of solutions
The shareholders of Optima Medical Limited have sold the company to Natus Medical Incorporated.
Optima Medical is one of the UK and Ireland’s leading supplier of neurodiagnostic equipment and accessories (EEG, Sleep, EMG, IOM). Since it was founded in 1999, Optima has installed thousands of systems in hospitals throughout the UK and Ireland. The company has built its reputation through supplying high-performance equipment combined with technical and clinical expertise. Its team consists of highly experienced engineers, product experts and clinical specialists trained and qualified to support customers throughout the life of their equipment.
Natus delivers solutions to screen, diagnose and treat disorders affecting the brain, neural pathways and eight sensory nervous systems, its aim being to advance the standard of care and improve patient outcomes and quality of life. Natus offers hardware, advanced software and algorithms, and consumables that provide stimulus, acquire and monitor physiological signals, and capture the body’s response. With sales in over 100 countries, Natus is a global leader in neurodiagnostics.
With a long-standing history as a trusted distribution partner of Natus Medical, the acquisition of Optima signifies a significant step forward, elevating their already successful partnership to a new phase. Together, they are able to enhance their shared goal of providing industry leading products and exceptional customer support, bringing it closer to their customers within the British Isles.
Oaklins S&W, based in the UK, acted as lead advisor to the shareholders of Optima.


Sprechen Sie mit dem Deal-Team
Transaktionen
Cerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Mehr erfahrenBolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Mehr erfahreniwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Mehr erfahren